U.S. ex rel. Wetherholt v. Pfizer, Inc.
Oct 20, 2011OUTCOME: $14.5 million
Assisted in False Claims Act case against Pfizer alleging off-label promotion of its urology drug Detrol. Case was pursued on behalf of the qui tam whistleblowers without government intervention.
